LONG-TERM EFFICACY AND SAFETY OF PONATINIB IN HEAVILY PRETREATED LEUKEMIA PATIENTS: 4-YEAR RESULTS FROM THE PIVOTAL PHASE 2 PACE TRIAL
File(s)60-61.pdf (95.76 KB)
Published version
Author(s)
Type
Conference Paper
Date Issued
2016-06-01
Date Acceptance
2016-01-01
Citation
Haematologica, 2016, 101, pp.60-61
ISSN
0390-6078
Publisher
Ferrata Storti Foundation
Start Page
60
End Page
61
Journal / Book Title
Haematologica
Volume
101
Copyright Statement
LONG-TERM EFFICACY AND SAFETY OF PONATINIB IN HEAVILY PRETREATED LEUKEMIA PATIENTS: 4-YEAR RESULTS FROM THE PIVOTAL PHASE 2 PACE TRIAL. Haematologica vol. 101 no. s1 60-61. ©2016 by Ferrata-Storti Foundation/European Hematology Association. All rights reserved.
Sponsor
National Institute for Health Research
Grant Number
NF-SI-0611-10275
Source
21st Congress of the European Hematology Association
Subjects
Science & Technology
Life Sciences & Biomedicine
Hematology
Immunology
1102 Cardiovascular Medicine And Haematology
Publication Status
Published
Start Date
2016-06-09
Finish Date
2016-06-12
Coverage Spatial
Copenhagen, Denmark